Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis
- PMID: 2502256
- PMCID: PMC1836658
- DOI: 10.1136/bmj.298.6684.1363
Controlled trial of propranolol to prevent recurrent variceal bleeding in patients with non-cirrhotic portal fibrosis
Abstract
Fifty patients with non-cirrhotic portal fibrosis who were admitted to hospital because of upper gastrointestinal bleeding were randomly assigned to treatment with either oral propranolol given in doses that reduced the resting pulse rate by 25% (25 patients) or with a placebo (25 patients). One year after the start of the study 20 patients in the propranolol group and five patients in the placebo group were free from recurrent gastrointestinal bleeding (p less than 0.0001). Giving continuous oral propranolol treatment is therefore effective in preventing recurrent upper gastrointestinal bleeding in patients with non-cirrhotic portal fibrosis.
Similar articles
-
Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.N Engl J Med. 1981 Dec 3;305(23):1371-4. doi: 10.1056/NEJM198112033052302. N Engl J Med. 1981. PMID: 7029276 Clinical Trial.
-
Propranolol alone may not be acceptable to prevent first esophageal variceal bleeding in Japanese cirrhotic patients: randomized controlled trial.J Gastroenterol Hepatol. 2004 May;19(5):576-81. doi: 10.1111/j.1440-1746.2003.03331.x. J Gastroenterol Hepatol. 2004. PMID: 15086603 Clinical Trial.
-
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis.N Engl J Med. 1983 Dec 22;309(25):1539-42. doi: 10.1056/NEJM198312223092502. N Engl J Med. 1983. PMID: 6361553 Clinical Trial.
-
Prevention of first variceal bleeding: new prospects.J Pak Med Assoc. 1992 Feb;42(2):47-51. J Pak Med Assoc. 1992. PMID: 1349361 Review. No abstract available.
-
Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.Eur J Med Res. 1996 Jun 25;1(9):407-16. Eur J Med Res. 1996. PMID: 9353240 Review.
Cited by
-
Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.Dig Dis Sci. 2005 Aug;50(8):1538-47. doi: 10.1007/s10620-005-2877-1. Dig Dis Sci. 2005. PMID: 16110851 Clinical Trial.
-
β-Blockers Improve Presinusoidal Portal Hypertension.Dig Dis Sci. 2018 Nov;63(11):3153-3157. doi: 10.1007/s10620-018-5186-1. Epub 2018 Jul 12. Dig Dis Sci. 2018. PMID: 30003386 Free PMC article.
-
Profiling lifetime episodes of upper gastrointestinal bleeding among patients from rural Sub-Saharan Africa where schistosoma mansoni is endemic.Pan Afr Med J. 2016 Aug 3;24:296. doi: 10.11604/pamj.2016.24.296.9755. eCollection 2016. Pan Afr Med J. 2016. PMID: 28154651 Free PMC article.
-
Long-term results of esophagogastric devascularization and splenectomy associated with endoscopic treatment in schistosomal portal hypertension.World J Surg. 2010 Nov;34(11):2682-8. doi: 10.1007/s00268-010-0717-8. World J Surg. 2010. PMID: 20645097
-
Gastrointestinal complications of schistosomiasis.Curr Gastroenterol Rep. 2001 Aug;3(4):293-303. doi: 10.1007/s11894-001-0052-1. Curr Gastroenterol Rep. 2001. PMID: 11469998
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical